Post by Kymos Group

The analysis of #nucleicacids, especially in biological matrices, is one of the newest services offered by the Kymos Group and carried out at its German subsidiary Prolytic. Maria Fauth, Head of the Oligonucleotides Department and Dr. Janine Lossie from OMEICOS Therapeutics GmbH share their perspectives on this promising field of nucleic acid-based biomarkers, therapeutic drugs, and other emerging therapeutic tools such as aptamers or antagomiRs. https://bit.ly/3AUEtjc #oligonucleotides #antagomirs #aptamers